Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers

SIMPLE SUMMARY: Immunotherapy targeting immune checkpoints and stromal cells in the tumor microenvironment is currently one of the most promising directions for tumor therapy. Ongoing studies suggest that CD73 plays an important role in the tumor immune process in certain tumors, however, the exact...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Kun, Zhang, Jingwei, Cao, Hui, Xiao, Gelei, Wang, Zeyu, Zhang, Xun, Zhang, Nan, Wu, Wantao, Zhang, Hao, Wang, Qianrong, Xu, Huilan, Cheng, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688912/
https://www.ncbi.nlm.nih.gov/pubmed/36428755
http://dx.doi.org/10.3390/cancers14225663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688912/
https://www.ncbi.nlm.nih.gov/pubmed/36428755
http://dx.doi.org/10.3390/cancers14225663

Ejemplares similares